GALWAY, IRELAND--November 4, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical company Novartis International AG (NYSE:NVS) (Basel, Switzerland) is axing more than half of the employees at its Irish active pharmaceutical ingredient (API) manufacturing operation at the Ringaskiddy campus in Cork by mid-2022.

Within this article: Details job cuts, impact, related activities in Europe